Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
Public ClinicalTrials.gov record NCT02348723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Evaluation of Dabigatran Etexilate Compared to warfarIn in pulmonaRy Vein Ablation: Assessment of an Uninterrupted periproCedUral alntIcoagulation sTrategy (The RE-CIRCUIT Trial)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this trial is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted warfarin regimen in Non-Valvular Atrial Fibrillation (NVAF) patients undergoing Atrial Fibrillation (AF) ablation in a PROBE (Prospective, randomized, open label, blinded end point) active controlled study. Secondary objectives are to assess additional safety endpoints and efficacy in this clinical setting. It is not intended to assess confirmatory hypothesis, this is an exploratory study.
Study identification
- NCT ID
- NCT02348723
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 678 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2015 (Actual)
- Primary completion
- Nov 11, 2016 (Actual)
- Completion
- Nov 14, 2016 (Actual)
- Last update posted
- Jan 29, 2018
2015 – 2016
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Cardiology, PA | Little Rock | Arkansas | 72205 | — |
| Mission Cardiovascular Research Institute | Fremont | California | 94538 | — |
| University of California | Sacramento | California | 95817 | — |
| Mercy Medical Group, a service of Dignity Health Medical Foundation | Sacramento | California | 95819 | — |
| University of California | San Francisco | California | 94143 | — |
| Southwest Florida Research, LLC | Naples | Florida | 34102 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Elkhart General Healthcare System | Elkhart | Indiana | 46514 | — |
| Tulane University Hospital and Clinic | New Orleans | Louisiana | 70112 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| St. Louis Heart and Vascular, P.C. | St Louis | Missouri | 63136 | — |
| New York Methodist Hospital | Brooklyn | New York | 11215 | — |
| University at Buffalo, The State University of New York | Buffalo | New York | 14203 | — |
| Staten Island University Hospital | Staten Island | New York | 10305 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104-5068 | — |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| University of Tennessee Methodist Physicians | Memphis | Tennessee | 38104 | — |
| North Texas Heart Center | Dallas | Texas | 75231 | — |
| St Luke's Health Baylor College of Medicine Med Center | Houston | Texas | 77030 | — |
| University of Utah Health Sciences Center | Salt Lake City | Utah | 84132 | — |
| Providence Regional Medical Center | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02348723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2018 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02348723 live on ClinicalTrials.gov.